Emma Guttman

Emma Guttman, MD, PhD, Waldman Professor of Dermatology and Immunology and Health System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai, is a global leader in inflammatory skin diseases. She directs the Occupational Dermatitis Clinic and the Lab for Inflammatory Skin Diseases, with major clinical and research contributions to understanding atopic dermatitis (AD) and alopecia areata.

• Educated at Tel-Aviv University Sackler School of Medicine (MD) and Bar-Ilan University (PhD)
• Board-certified in dermatology (Israel and U.S.)
• Developed broaden biomarker research for AD therapies

Her work redefined AD pathophysiology, enabling targeted drugs like dupilumab. Recent studies focus on Th2/Th22/IL-23 axis inhibitors and rare skin conditions (keloids, ichthyosis). With ~340 peer-reviewed publications, she co-founded the International Eczema Council and delivered keynote speeches globally.

Scientific Recognition

• Paul Ehrlich Award (2024, EAACI)
• Donald Y. M. Leung Lectureship (2021, AAAAI)
• Article of the Year Award (2021, Dermatits)

Her research translates to clinical trials and novel treatments, supported by industry collaborations with AbbVie, Regeneron, Eli Lilly, and others. The lab’s tape-strip transcriptomic profiling (2021) demonstrated early mechanistic responses to biologics, shaping personalized medicine approaches.